Struthers Inc.,

[NetShoe]

Struthers, Inc. Reports Third Quarter Operating Results
Business Wire - November 15, 2000 19:11

CHARLESTON, S.C.--(BW HealthWire)--Nov. 15, 2000--
Struthers, Inc. (OTC BB: STRU) today announced the operating results of its third quarter. Revenues for the three-month period ended September 30, 2000 totaled $969,960 as compared to $887,526 for the second quarter of 2000, representing an increase of $82,434 or 9.3% for the quarter.

Nine month revenues were $2,763,019 as compared to revenues of $ in the prior year.

Operating costs showed similar improvement during the third quarter. Exclusive of depreciation and amortization, operating costs decreased by $10,049 from $663,773 to $653,724 in the third quarter, a decrease of 1.5%. Total operating expenses including amortization and depreciation for the three months ended September 30, 2000 were $1,054,407 (109% of revenues) as compared to $948,627 (107% of revenues) for the second quarter of 2000, an increase of $105,780 or 11.1% over the previous quarter.

Nine month operating costs were $2,573,677 (93% of revenues) as compared to $279,798 in the year 1999. The percentage increase in operating expenses during the third quarter of 2000 is attributable to increases in amortization of intangible assets resulting from the acquisition of Elite Visions, Inc. (acquired June 1,2000) and costs related to registration of the company's stock (aggregating approximately $80,000). Exclusive of these costs, total operating costs would have declined as a percentage of revenues by approximately 8% when compared to the previous quarter.

Net loss for the three-month period ended September 30, 2000 was $538,844 as compared to $588,310 for the second quarter of 2000, a decrease of $49,466. Net loss for the nine-month period ended September 30, 2000 was $2,573,677 as compared to $279,798 in 1999 (a period prior to the acquisition of Legred Struthers Genetics, Inc., Elite Visions, Inc. and Muller A.I., Inc.) an increase of $2,293,879. Losses before depreciation, interest and taxes decreased during the quarter ended September 30, 2000 to $138,161 from $303,456 for the second quarter. Year to date losses before depreciation, interest and taxes were $438,707 compared to $279,798 in the prior year. The net loss per common share - basis and diluted was less than $.01 per share for third quarter 2000 and the nine months ended September 30, 2000 and 1999.

Struthers, Inc. a world leader in animal reproductive biotechnology was the first company in the world to transfer porcine embryos transatlantic. Further product development lead to the world's first piglets to be born using Struthers' proprietary non-surgical embryo transfer technique involving the use of the Gourley Scope TM. Struthers has since acquired Legred Struthers Genetics, Inc. a top 10 suppliers of porcine genetics, and constructed one of the Nations largest state-of-the-art boar stud facilities located in Minnesota. The Company acquired Muller AI, Inc. a nationally recognized retailer of artificial insemination products, and acquired Elite Visions, Inc. which developed the Gourley Scope TM and distributes the Company's Tender Prime TM line of naturally raised meat and other natural food products. Struthers also has alliances with meat processors and producers of pork, chicken, deer, and sheep.

Dr. Douglas W. Beatty, CEO of Struthers commenting on the operating results for the third quarter, stated, "this year reflects a rapid acceleration of our growth, for which we have invested extensively in a solid corporate platform through Company acquisitions and the development of new advanced reproductive biotechnology products and services. It has been an exciting year and we are pleased that Struthers continues to grow its animal producer network and revenue streams. Struthers has also invested in numerous animal husbandry production facilities to compete both nationally and internationally. I also expect further growth as we continue to develop and grow our distribution channels for our high-end naturally raised meat and other natural products for our wholesale and retail customers. Further expansion and sales internationally of our unique reproductive biotechnology system, in my opinion will reflect in a significant improvement in our growth and in the successful implementation of our global business plan."

For further information on Struthers, Inc., visit their web site at
http://www.struthersinc.com
.

For further information on Tender Prime TM, visit their web site at
http://www.tenderprime.com .

This is not a solicitation to buy securities and does not purport to be a complete analysis of Struthers, Inc. Investing in securities is highly speculative and carries a degree of risk. Past performance does not guarantee future results. The matters discussed in this release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, and section 27A of the securities act of 1933, as amended, that involves risks and uncertainties. Readers are cautioned as to potential risks, as discussed in the section included in the Company's Annual Report and on Form 10 Registration filed recently with the SEC, and the risks discussed in the Company's other filings with the SEC.

Cheers

Voluntary Disclosure: Strong Buy : Long and Short Term